바이오테크 보도자료
-
- Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care
- Takeda (TSE:4502/NYSE:TAK) today announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO...
- 03월 29일 11:45
-
- Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors
- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its par...
- 03월 29일 10:25
-
- Nearly Half of Global C-Suites Plan U.S. Expansion Within 12 Months, as Supply Chain and Capital Access Drive Growth
- Nearly half (45%) of global C-suite leaders plan to establish a legal entity in the United States within the next 12 months, highlighting continued demand for access to the U.S. market. This finding from the latest research by CSC—the leading prov...
- 03월 27일 13:40
-
- Rubedo Life Sciences Announces Positive Preliminary Phase 1 Clinical Trial Results for Lead Drug Candidate RLS-1496 in Patients with Plaque Psoriasis, Atopic Dermatitis, and Skin Aging
- Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective cellular rejuvenation medicines targeting aging cells, today announced preliminary results from a single-center, asce...
- 03월 27일 12:00
-
- Invivoscribe® Expands IVDR Portfolio with IdentiClone® Dx IGH Assay Certification
- Invivoscribe, a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to announce that its IdentiClone Dx IGH Assay has received In Vitro Diagnostic Regulation (IVDR) 2017/746 Class C certification in the E...
- 03월 27일 11:10
-
- Andersen Consulting Enters Collaboration Agreement with Solutia
- Andersen Consulting expands its presence in Spain through a Collaboration Agreement with Solutia, a firm specializing in occupational and workplace health solutions, as well as recruitment across the life sciences and healthcare sectors. Founded i...
- 03월 27일 10:40
-
- Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery
- MindWave Innovations Inc., a Delaware corporation and wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (“APUS” or the “Company”) (NYSE American: APUS), today announced that on March 20, 2026, Inscobee Inc. (KS:006490) and its wholly own...
- 03월 26일 16:30
-
- Biocytogen Announces Strategic Collaboration with Moonlight Bio to Advance Cell Therapies Using Library of Antibody Binders
- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced a strategic ...
- 03월 24일 15:20
-
- NTT DATA Verified the Effectiveness of AI Consumer Agents in Kao’s Product Development Research, Driving Greater Operational Efficiency and Sophistication
- NTT DATA, a global leader in AI, digital business and technology services, today announced the success of its “AI Consumers” proof of concept (PoC) for a makeup brand operated by Kao Corporation, a leading Japanese consumer goods company and a maj...
- 03월 19일 13:49
-
- Secure Code Warrior Launches Trust Agent: AI to Enable Safe, Scalable AI-Driven Development
- Secure Code Warrior today announced SCW Trust Agent: AI, the industry’s first governance solution designed to make AI influence in software development visible, attributable, and enforceable at the point of commit — enabling enterprises to scale A...
- 03월 18일 17:15
전시회
